Evidence map›Paper›PMID 32363206›Full record

ArticleERJ open research2020

Efficacy and safety of two doses of budesonide/formoterol fumarate metered dose inhaler in COPD.

Nicola A Hanania, Alberto Papi, Antonio Anzueto, Fernando J Martinez, Kimberly A Rossman, Christy S Cappelletti, Elizabeth A Duncan, Jack S Nyberg, Paul M Dorinsky

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ERJ open research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Discordant diagnostic criteria for pneumonia in COPD trials: a review.European respiratory review : an official journal of the European Respiratory Society · 2021
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Nicola A HananiaSection of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, TX, USA.
Alberto PapiResearch Centre on Asthma and COPD, Dept of Medical Sciences, University of Ferrara, Ferrara, Italy.ORCID https://orcid.org/0000-0002-6924-4500
Antonio AnzuetoPulmonary Medicine and Critical Care, University of Texas Health Science Center and South Texas Veterans Health Care System, San Antonio, TX, USA.
Fernando J MartinezJoan and Sanford I. Weill Dept of Medicine, Weill Cornell Medicine, New York, NY, USA.
Kimberly A RossmanAstraZeneca, Morristown, NJ, USA.
Christy S CappellettiAstraZeneca, Durham, NC, USA.
Elizabeth A DuncanAstraZeneca, Durham, NC, USA.
Jack S NybergFormer employee of AstraZeneca, Morristown, NJ, USA.
Paul M DorinskyAstraZeneca, Durham, NC, USA.
AstraZeneca (United States) · USBaylor College of Medicine · USCornell University · USThe University of Texas Health Science Center at San Antonio · USUniversity of Ferrara · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inhaled corticosteroid/long-acting β

Identifiers

PMID32363206
PMCPMC7184113
OpenAlexW3020329335

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.